Administration of Intranasal Midazolam for Anxiety in Palliative Care

Summary

The goal of this double-blind, randomized, placebo-controlled parallel-group multicenter exploratory pilot study (three study arms) is to describe effects and safety of different doses of intranasal midazolam to treat acute anxiety in palliative care patients, while providing pharmacokinetic and pharmacodynamic data.

Timeline

Start

2024-12-20

Primary completion

2025-09

Completion

2025-10

Drugs

Indications